Application of a sepsis flow chip (SFC) assay for the molecular diagnosis of paediatric sepsis

Research output: Contribution to journalArticlepeer-review

Abstract

A delay in detecting sepsis pathogens is a problematic issue for determining definitive antibiotic therapy for the causative pathogens. The gold standard method for sepsis is blood culture but this requires 3 days to detect the definitive pathogen. Molecular methods offer rapid identification of pathogens. We evaluated the use of sepsis flow chip (SFC) assay for identifying pathogens from children with sepsis. Blood samples from children with sepsis were collected and incubated in a culture device. Positive samples were subjected to amplification-hybridization using SFC assay and culture. A total of 94 samples from 47 patients were recovered, from which 25 isolates were recovered, including Klebsiella pneumoniae (11) and Staphylococcus epidermidis (6). From 25 positive blood culture bottles subjected to SFC assay, 24 genus/species and 18 resistance genes were detected. The sensitivity, specificity and conformity was 80, 94.2 and 94.68 % respectively. SFC assay offers promise to identify pathogens from positive blood culture in paediatric patients with sepsis and may support the antimicrobial stewardship programme in hospitals.

Original languageEnglish
JournalAccess Microbiology
Volume5
Issue number4
DOIs
Publication statusPublished - 1 Apr 2023

Keywords

  • amplification-hybridization
  • paediatric sepsis
  • blood culture
  • antimicrobial stewardship

Fingerprint

Dive into the research topics of 'Application of a sepsis flow chip (SFC) assay for the molecular diagnosis of paediatric sepsis'. Together they form a unique fingerprint.

Cite this